Kemerovo, Kemerovo, Russian Federation
Kemerovo, Kemerovo, Russian Federation
Kemerovo, Kemerovo, Russian Federation
Ocenivali chastotu soputstvuyuschih zabolevaniy pri ankiloziruyuschem spondilite (AS). Proanalizirovano 86 istoriy bolezni pacientov (59 muzhchin i 27 zhenschin) v vozraste ot 21 goda do 62 let. Kriteriyami vklyucheniya yavlyalsya dostovernyy diagnoz AS, ustanovlennyy po modificirovannym N'yu-Yorkskim kriteriyam 1984 g. U vseh pacientov byla provedena rentgenografiya kostey taza, FGDS i dvuhenergeticheskaya densitometriya s ispol'zovaniem stacionarnogo rentgenovskogo dvuhenergeticheskogo kostnogo densitometra «Exceell» XR-46 («Norland», USA).Ustanovleno, chto soputstvuyuschie zabolevaniya imeli 72 (83,7%) pacienta AS, iz nih 31 (36%) — odno, 12 (14%) — dva, 28 (32,5%) — tri, 1 (1,2%) — chetyre. Chasche vsego registrirovalis' zabolevaniya pischevaritel'noy sistemy u 76,7% pacientov. Kardiovaskulyarnaya patologiya otmechena u 36 (41,9%) bol'nyh, naibolee chasto AG — u 34 (39,5%). Osteopenicheskiy sindrom vyyavlen u 43% bol'nyh, iz nih osteoporoz u 32,5%, prichem, snizhenie MPK opredelyalos' kak v sheyke bedra, tak i v poyasnichnom otdele pozvonochnika. Lezhaschee v osnove AS hronicheskoe vospalenie zapuskaet mnogochislennye patologicheskie mehanizmy i privodit k porazheniyu bol'shinstva organov i sistem, chto harakterizuet dannoe zabolevanie, kak zabolevanie s vysokoy komorbidnost'yu.
ankiloziruyuschiy spondilit, komorbidnost'
1. Van den Akker M. Comorbidity or multimorbidity: what's in a name? // Eur J Gen Pract. 1996; 20: 65-70.
2. Van den Bussche H, Schwn G, Kolonko T. Patterns of ambulatorytmedical care utilization in elderly patients with special reference to chronic diseases and multimorbidity - results from a claims data based observational study in Germany // BMC Geriatr. 2011; 11: 54.
3. Huntley AL. et al. Measures of Multimorbidity and Morbidity Burden for Use in Primary Are and Community Settings: A Systematic Review and Guide // Annals of Family Medicine. 2012;10 (2): 134-41.
4. Stolwijk C, van Tubergen A, Ramiro S. et al. Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis // Rheumatology. 2014; 53: 1054-64.
5. Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide populationbased study // Ann Rheum Dis. 2010; 69: 1165-1168.
6. Gubar' E.E., Erdes Sh.F. Osteoporoz u bol'nyh ankiloziruyuschim spondilitom // Nauchno-prakticheskaya revmatologiya. 2013;51(5):553-62.
7. Oldroyd J, Schachna L, Buchbinder R. et al. Ankilosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database // International Journal of Rheumatology. 2009; 68569.
8. Em S, Bozkurt M, Caglayan M. et al. Ankilozan spondilitli hastalarda komorbit hastaliklarin degerlendirmesi // Dicle Medical Journal. 2014; 41(4): 662-666.
9. Podryadnova M.V., Erdes Sh.F., Balabanova R.M. // Komorbidnost' pri ankiloziruyuschem spondilite (predvaritel'nye dannye). Doktor.ru. 2013. 6(84): 39-42.
10. Gordeev A.V., Galushko E.A., Nasonov E.L. Koncepciya mul'timorbidnosti v revmatologicheskoy praktike // Nauchno-prakticheskaya revmatologiya. 2014 №4, tom 52, S. 362-365.
